Product Description: Plutavimab a human IgG1-κ anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD)[1][2].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Plutavimab. IMGT/mAb-DB./[2]Williams, et al. Engineering of antibodies to coronavirus SARS-CoV-2 for diagnosis and treatment. World Intellectual Property Organization, WO2023070051 A1. 2023-04-27.